A non-exclusive license agreement in non-clinical field products and services just executed with Minerva Biotechnologies on the patents related to iPS cell technology that we have been granted a sublicensing right by Kyoto University.
Published patent information have been released to the list of our “Patent Information”. Please visit the reformed page for further details.
Our office will be closed for the summer holiday from Monday 10th August 2015 to Wednesday 12th August 2015.
Please understand that our earliest replay to any inquiries received during the above period will be made on or after Thursday 13th August 2015.
We apologize for your inconvenience this may cause you during this period.
We are pleased to announce that we moved to a new office on May 15, 2015.
207 International Science Innovation Building East Wing.
36-1 Yoshida-honmachi, Sakyo-ku, Kyoto
New Phone / Fax number
Tel：+81 75-754-0625 / Fax：+81 75-761-3577
We are present at “2015 BIO International Convention” on June 15-18 in Philadelphia, Pennsylvania.
We executed a non-exclusive license agreement with Pluriomics B.V. a Dutch company, which provides iPS cell derived cells such as cardiomyocytes for research use, on the patents related to iPS cell technology which we have been granted a sublicensing right from Kyoto University.
We are present at ChinaBio2015 in Shanghai,China on April 15-16.
A non-exclusive license agreement concluded with Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry, on the patents related to iPS cell technology which we have been granted a sublicensing right from Kyoto University, the license permitting distribution of iPS cells for use in research and clinical trials.
We renewed License website to make it easier for customers to utilize. Mainly, Patent portfolio and License program are update.
A non-exclusive license agreement concluded with EMD Millopore on the patents related to iPS cell technology which we have been granted a sublicensing right by Kyoto University.